UPG-111
UPG-111 is a peptide compound that acts as a negative allosteric modulator of the Urotensin II receptor (UTR). UPG-111 exhibits a dual inhibitory effect on the vasoconstriction induced by UTR agonists - it reduces both the maximum response intensity and the sensitivity of the agonist. UPG-111 does not induce calcium release or cause contraction of the endothelium-deprived rat aortic rings. UPG-111 can be used for the study of various diseases related to the angiotensinergic system.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 3090687-02-5
- 화학식: C64H87N13O17S2
- 분자량:1374.58
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Chemical Information
-
CAS No. 3090687-02-5
-
분자량 1374.58
-
화학식 C64H87N13O17S2
-
Sequence
{hSer}-{TPED}-{Pen}-Phe-{d-Trp}-{Orn}-Tyr-Cys-Val (Disulfide bridge: Pen-Cys)
-
Sequence Shortening
{hSer}-{TPED}-{Pen}-F-{d-Trp}-{Orn}-YCV (Disulfide bridge: Pen-Cys)
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- UPG-111
- 3090687-02-5
- UPG111
- UPG 111
- Urotensin Receptor
- Urotensin II receptor (UTR) modulators
- Negative allosteric modulator (NAM)
- Lateral allostery
- GPCR multimeric model
- Structure-activity relationship (SAR)
- N-terminal peptide engineering
- Noncompetitive antagonism
- Calcium mobilization
- Rat aorta contraction
- Inhibitor
- inhibitor
- inhibit